Both SLC38A5 and RRM1 mRNA levels were higher in gemcitabine-resistant pancreatic cancer tissues than in gemcitabine-sensitive patient tissues (Figure 1E). The gene discussed is SLC38A5; the disease is familial pancreatic carcinoma.